Table 5.
Group A | Group B | Group C | ||||
---|---|---|---|---|---|---|
OR (95%CI) | P | OR (95%CI) | P | OR (95%CI) | P | |
APN | 0.487 (0.349,0.680) |
0.001 | 0.503 (0.317,0.798) |
0.004 | 0.664 (0.530,0.833) |
0.001 |
CTRP1 | 1.377 (1.214,1.561) |
0.001 | 1.121 (0.949,1.324) |
0.018 | 1.058 (0.953,1.174) |
0.024 |
TNF-α | 1.007 (0.994,1.021) |
0.292 | 1.023 (1.001,1.046) |
0.039 | 1.012 (0.999,1.025) |
0.061 |
IL6 | 1.010 (0.950,1.074) |
0.746 | 0.979 (0.894,1.072) |
0.642 | 1.232 (1.157,1.312) |
0.001 |
Group A: EH patients with both LVH and MAU.
Group B: EH patients with MAU.
Group C: EH patients with LVH.